0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Morquio Syndrome Treatment Market Insights, Forecast to 2028
Published Date: March 2022
|
Report Code: QYRE-Auto-34H5635
Home | Market Reports | Health | Health Conditions | Genetic Disorders
Global Morquio Syndrome Treatment Market Insights Forecast to 2028

Global Morquio Syndrome Treatment Market Insights, Forecast to 2028

Code: QYRE-Auto-34H5635
Report
March 2022
118 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
Morquio syndrome is a type of mucopolysaccharide metabolic disorder, that is, type Ⅳ in mucopolysaccharide storage disease, also known as hereditary cartilage dystrophy syndrome
Market Analysis and Insights: Global Morquio Syndrome Treatment Market

The global Morquio Syndrome Treatment market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, Morquio A accounting for % of the Morquio Syndrome Treatment global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Hospital segment is altered to an % CAGR throughout this forecast period.
China Morquio Syndrome Treatment market size is valued at US$ million in 2021, while the North America and Europe Morquio Syndrome Treatment are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Morquio Syndrome Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Morquio Syndrome Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Morquio Syndrome Treatment market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Morquio Syndrome Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Morquio Syndrome Treatment market.
Global Morquio Syndrome Treatment Scope and Market Size
Morquio Syndrome Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Morquio Syndrome Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Morquio A
Morquio B

Segment by Application

Hospital
Clinic
Others

BY COMPANY

BioMarin
Genzyme Corporation,
Shire
JCR Pharmaceuticals
Sanofi
Sangamo Therapeutics
Green Cross
Concert Pharmaceuticals
Alexion Pharmaceuticals
Roche
Pfizer
Lupin
Cambrex Corporation
Cipla
Bayer
Daiichi Sankyo

BY REGION

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Morquio Syndrome Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Morquio A
1.2.3 Morquio B
1.3 Market by Application
1.3.1 Global Morquio Syndrome Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Morquio Syndrome Treatment Market Perspective (2017-2028)
2.2 Morquio Syndrome Treatment Growth Trends by Region
2.2.1 Morquio Syndrome Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Morquio Syndrome Treatment Historic Market Size by Region (2017-2022)
2.2.3 Morquio Syndrome Treatment Forecasted Market Size by Region (2023-2028)
2.3 Morquio Syndrome Treatment Market Dynamics
2.3.1 Morquio Syndrome Treatment Industry Trends
2.3.2 Morquio Syndrome Treatment Market Drivers
2.3.3 Morquio Syndrome Treatment Market Challenges
2.3.4 Morquio Syndrome Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Morquio Syndrome Treatment Players by Revenue
3.1.1 Global Top Morquio Syndrome Treatment Players by Revenue (2017-2022)
3.1.2 Global Morquio Syndrome Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Morquio Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Morquio Syndrome Treatment Revenue
3.4 Global Morquio Syndrome Treatment Market Concentration Ratio
3.4.1 Global Morquio Syndrome Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Morquio Syndrome Treatment Revenue in 2021
3.5 Morquio Syndrome Treatment Key Players Head office and Area Served
3.6 Key Players Morquio Syndrome Treatment Product Solution and Service
3.7 Date of Enter into Morquio Syndrome Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Morquio Syndrome Treatment Breakdown Data by Type
4.1 Global Morquio Syndrome Treatment Historic Market Size by Type (2017-2022)
4.2 Global Morquio Syndrome Treatment Forecasted Market Size by Type (2023-2028)
5 Morquio Syndrome Treatment Breakdown Data by Application
5.1 Global Morquio Syndrome Treatment Historic Market Size by Application (2017-2022)
5.2 Global Morquio Syndrome Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Morquio Syndrome Treatment Market Size (2017-2028)
6.2 North America Morquio Syndrome Treatment Market Size by Type
6.2.1 North America Morquio Syndrome Treatment Market Size by Type (2017-2022)
6.2.2 North America Morquio Syndrome Treatment Market Size by Type (2023-2028)
6.2.3 North America Morquio Syndrome Treatment Market Share by Type (2017-2028)
6.3 North America Morquio Syndrome Treatment Market Size by Application
6.3.1 North America Morquio Syndrome Treatment Market Size by Application (2017-2022)
6.3.2 North America Morquio Syndrome Treatment Market Size by Application (2023-2028)
6.3.3 North America Morquio Syndrome Treatment Market Share by Application (2017-2028)
6.4 North America Morquio Syndrome Treatment Market Size by Country
6.4.1 North America Morquio Syndrome Treatment Market Size by Country (2017-2022)
6.4.2 North America Morquio Syndrome Treatment Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Morquio Syndrome Treatment Market Size (2017-2028)
7.2 Europe Morquio Syndrome Treatment Market Size by Type
7.2.1 Europe Morquio Syndrome Treatment Market Size by Type (2017-2022)
7.2.2 Europe Morquio Syndrome Treatment Market Size by Type (2023-2028)
7.2.3 Europe Morquio Syndrome Treatment Market Share by Type (2017-2028)
7.3 Europe Morquio Syndrome Treatment Market Size by Application
7.3.1 Europe Morquio Syndrome Treatment Market Size by Application (2017-2022)
7.3.2 Europe Morquio Syndrome Treatment Market Size by Application (2023-2028)
7.3.3 Europe Morquio Syndrome Treatment Market Share by Application (2017-2028)
7.4 Europe Morquio Syndrome Treatment Market Size by Country
7.4.1 Europe Morquio Syndrome Treatment Market Size by Country (2017-2022)
7.4.2 Europe Morquio Syndrome Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Morquio Syndrome Treatment Market Size (2017-2028)
8.2 Asia-Pacific Morquio Syndrome Treatment Market Size by Type
8.2.1 Asia-Pacific Morquio Syndrome Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Morquio Syndrome Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Morquio Syndrome Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Morquio Syndrome Treatment Market Size by Application
8.3.1 Asia-Pacific Morquio Syndrome Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Morquio Syndrome Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Morquio Syndrome Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Morquio Syndrome Treatment Market Size by Region
8.4.1 Asia-Pacific Morquio Syndrome Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Morquio Syndrome Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Morquio Syndrome Treatment Market Size (2017-2028)
9.2 Latin America Morquio Syndrome Treatment Market Size by Type
9.2.1 Latin America Morquio Syndrome Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Morquio Syndrome Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Morquio Syndrome Treatment Market Share by Type (2017-2028)
9.3 Latin America Morquio Syndrome Treatment Market Size by Application
9.3.1 Latin America Morquio Syndrome Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Morquio Syndrome Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Morquio Syndrome Treatment Market Share by Application (2017-2028)
9.4 Latin America Morquio Syndrome Treatment Market Size by Country
9.4.1 Latin America Morquio Syndrome Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Morquio Syndrome Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Morquio Syndrome Treatment Market Size (2017-2028)
10.2 Middle East & Africa Morquio Syndrome Treatment Market Size by Type
10.2.1 Middle East & Africa Morquio Syndrome Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Morquio Syndrome Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Morquio Syndrome Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Morquio Syndrome Treatment Market Size by Application
10.3.1 Middle East & Africa Morquio Syndrome Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Morquio Syndrome Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Morquio Syndrome Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Morquio Syndrome Treatment Market Size by Country
10.4.1 Middle East & Africa Morquio Syndrome Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Morquio Syndrome Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 BioMarin
11.1.1 BioMarin Company Details
11.1.2 BioMarin Business Overview
11.1.3 BioMarin Morquio Syndrome Treatment Introduction
11.1.4 BioMarin Revenue in Morquio Syndrome Treatment Business (2017-2022)
11.1.5 BioMarin Recent Developments
11.2 Genzyme Corporation,
11.2.1 Genzyme Corporation, Company Details
11.2.2 Genzyme Corporation, Business Overview
11.2.3 Genzyme Corporation, Morquio Syndrome Treatment Introduction
11.2.4 Genzyme Corporation, Revenue in Morquio Syndrome Treatment Business (2017-2022)
11.2.5 Genzyme Corporation, Recent Developments
11.3 Shire
11.3.1 Shire Company Details
11.3.2 Shire Business Overview
11.3.3 Shire Morquio Syndrome Treatment Introduction
11.3.4 Shire Revenue in Morquio Syndrome Treatment Business (2017-2022)
11.3.5 Shire Recent Developments
11.4 JCR Pharmaceuticals
11.4.1 JCR Pharmaceuticals Company Details
11.4.2 JCR Pharmaceuticals Business Overview
11.4.3 JCR Pharmaceuticals Morquio Syndrome Treatment Introduction
11.4.4 JCR Pharmaceuticals Revenue in Morquio Syndrome Treatment Business (2017-2022)
11.4.5 JCR Pharmaceuticals Recent Developments
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Morquio Syndrome Treatment Introduction
11.5.4 Sanofi Revenue in Morquio Syndrome Treatment Business (2017-2022)
11.5.5 Sanofi Recent Developments
11.6 Sangamo Therapeutics
11.6.1 Sangamo Therapeutics Company Details
11.6.2 Sangamo Therapeutics Business Overview
11.6.3 Sangamo Therapeutics Morquio Syndrome Treatment Introduction
11.6.4 Sangamo Therapeutics Revenue in Morquio Syndrome Treatment Business (2017-2022)
11.6.5 Sangamo Therapeutics Recent Developments
11.7 Green Cross
11.7.1 Green Cross Company Details
11.7.2 Green Cross Business Overview
11.7.3 Green Cross Morquio Syndrome Treatment Introduction
11.7.4 Green Cross Revenue in Morquio Syndrome Treatment Business (2017-2022)
11.7.5 Green Cross Recent Developments
11.8 Concert Pharmaceuticals
11.8.1 Concert Pharmaceuticals Company Details
11.8.2 Concert Pharmaceuticals Business Overview
11.8.3 Concert Pharmaceuticals Morquio Syndrome Treatment Introduction
11.8.4 Concert Pharmaceuticals Revenue in Morquio Syndrome Treatment Business (2017-2022)
11.8.5 Concert Pharmaceuticals Recent Developments
11.9 Alexion Pharmaceuticals
11.9.1 Alexion Pharmaceuticals Company Details
11.9.2 Alexion Pharmaceuticals Business Overview
11.9.3 Alexion Pharmaceuticals Morquio Syndrome Treatment Introduction
11.9.4 Alexion Pharmaceuticals Revenue in Morquio Syndrome Treatment Business (2017-2022)
11.9.5 Alexion Pharmaceuticals Recent Developments
11.10 Roche
11.10.1 Roche Company Details
11.10.2 Roche Business Overview
11.10.3 Roche Morquio Syndrome Treatment Introduction
11.10.4 Roche Revenue in Morquio Syndrome Treatment Business (2017-2022)
11.10.5 Roche Recent Developments
11.11 Pfizer
11.11.1 Pfizer Company Details
11.11.2 Pfizer Business Overview
11.11.3 Pfizer Morquio Syndrome Treatment Introduction
11.11.4 Pfizer Revenue in Morquio Syndrome Treatment Business (2017-2022)
11.11.5 Pfizer Recent Developments
11.12 Lupin
11.12.1 Lupin Company Details
11.12.2 Lupin Business Overview
11.12.3 Lupin Morquio Syndrome Treatment Introduction
11.12.4 Lupin Revenue in Morquio Syndrome Treatment Business (2017-2022)
11.12.5 Lupin Recent Developments
11.13 Cambrex Corporation
11.13.1 Cambrex Corporation Company Details
11.13.2 Cambrex Corporation Business Overview
11.13.3 Cambrex Corporation Morquio Syndrome Treatment Introduction
11.13.4 Cambrex Corporation Revenue in Morquio Syndrome Treatment Business (2017-2022)
11.13.5 Cambrex Corporation Recent Developments
11.14 Cipla
11.14.1 Cipla Company Details
11.14.2 Cipla Business Overview
11.14.3 Cipla Morquio Syndrome Treatment Introduction
11.14.4 Cipla Revenue in Morquio Syndrome Treatment Business (2017-2022)
11.14.5 Cipla Recent Developments
11.15 Bayer
11.15.1 Bayer Company Details
11.15.2 Bayer Business Overview
11.15.3 Bayer Morquio Syndrome Treatment Introduction
11.15.4 Bayer Revenue in Morquio Syndrome Treatment Business (2017-2022)
11.15.5 Bayer Recent Developments
11.16 Daiichi Sankyo
11.16.1 Daiichi Sankyo Company Details
11.16.2 Daiichi Sankyo Business Overview
11.16.3 Daiichi Sankyo Morquio Syndrome Treatment Introduction
11.16.4 Daiichi Sankyo Revenue in Morquio Syndrome Treatment Business (2017-2022)
11.16.5 Daiichi Sankyo Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
    Table 1. Global Morquio Syndrome Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Morquio A
    Table 3. Key Players of Morquio B
    Table 4. Global Morquio Syndrome Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Morquio Syndrome Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Morquio Syndrome Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Morquio Syndrome Treatment Market Share by Region (2017-2022)
    Table 8. Global Morquio Syndrome Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Morquio Syndrome Treatment Market Share by Region (2023-2028)
    Table 10. Morquio Syndrome Treatment Market Trends
    Table 11. Morquio Syndrome Treatment Market Drivers
    Table 12. Morquio Syndrome Treatment Market Challenges
    Table 13. Morquio Syndrome Treatment Market Restraints
    Table 14. Global Morquio Syndrome Treatment Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Morquio Syndrome Treatment Revenue Share by Players (2017-2022)
    Table 16. Global Top Morquio Syndrome Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Morquio Syndrome Treatment as of 2021)
    Table 17. Ranking of Global Top Morquio Syndrome Treatment Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Morquio Syndrome Treatment Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Morquio Syndrome Treatment Product Solution and Service
    Table 21. Date of Enter into Morquio Syndrome Treatment Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Morquio Syndrome Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Morquio Syndrome Treatment Revenue Market Share by Type (2017-2022)
    Table 25. Global Morquio Syndrome Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Morquio Syndrome Treatment Revenue Market Share by Type (2023-2028)
    Table 27. Global Morquio Syndrome Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Morquio Syndrome Treatment Revenue Share by Application (2017-2022)
    Table 29. Global Morquio Syndrome Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Morquio Syndrome Treatment Revenue Share by Application (2023-2028)
    Table 31. North America Morquio Syndrome Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Morquio Syndrome Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Morquio Syndrome Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Morquio Syndrome Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Morquio Syndrome Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Morquio Syndrome Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Morquio Syndrome Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Morquio Syndrome Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Morquio Syndrome Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Morquio Syndrome Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Morquio Syndrome Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Morquio Syndrome Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Morquio Syndrome Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Morquio Syndrome Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Morquio Syndrome Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Morquio Syndrome Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Morquio Syndrome Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Morquio Syndrome Treatment Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Morquio Syndrome Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Morquio Syndrome Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Morquio Syndrome Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Morquio Syndrome Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Morquio Syndrome Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Morquio Syndrome Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Morquio Syndrome Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Morquio Syndrome Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Morquio Syndrome Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Morquio Syndrome Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Morquio Syndrome Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Morquio Syndrome Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 61. BioMarin Company Details
    Table 62. BioMarin Business Overview
    Table 63. BioMarin Morquio Syndrome Treatment Product
    Table 64. BioMarin Revenue in Morquio Syndrome Treatment Business (2017-2022) & (US$ Million)
    Table 65. BioMarin Recent Developments
    Table 66. Genzyme Corporation, Company Details
    Table 67. Genzyme Corporation, Business Overview
    Table 68. Genzyme Corporation, Morquio Syndrome Treatment Product
    Table 69. Genzyme Corporation, Revenue in Morquio Syndrome Treatment Business (2017-2022) & (US$ Million)
    Table 70. Genzyme Corporation, Recent Developments
    Table 71. Shire Company Details
    Table 72. Shire Business Overview
    Table 73. Shire Morquio Syndrome Treatment Product
    Table 74. Shire Revenue in Morquio Syndrome Treatment Business (2017-2022) & (US$ Million)
    Table 75. Shire Recent Developments
    Table 76. JCR Pharmaceuticals Company Details
    Table 77. JCR Pharmaceuticals Business Overview
    Table 78. JCR Pharmaceuticals Morquio Syndrome Treatment Product
    Table 79. JCR Pharmaceuticals Revenue in Morquio Syndrome Treatment Business (2017-2022) & (US$ Million)
    Table 80. JCR Pharmaceuticals Recent Developments
    Table 81. Sanofi Company Details
    Table 82. Sanofi Business Overview
    Table 83. Sanofi Morquio Syndrome Treatment Product
    Table 84. Sanofi Revenue in Morquio Syndrome Treatment Business (2017-2022) & (US$ Million)
    Table 85. Sanofi Recent Developments
    Table 86. Sangamo Therapeutics Company Details
    Table 87. Sangamo Therapeutics Business Overview
    Table 88. Sangamo Therapeutics Morquio Syndrome Treatment Product
    Table 89. Sangamo Therapeutics Revenue in Morquio Syndrome Treatment Business (2017-2022) & (US$ Million)
    Table 90. Sangamo Therapeutics Recent Developments
    Table 91. Green Cross Company Details
    Table 92. Green Cross Business Overview
    Table 93. Green Cross Morquio Syndrome Treatment Product
    Table 94. Green Cross Revenue in Morquio Syndrome Treatment Business (2017-2022) & (US$ Million)
    Table 95. Green Cross Recent Developments
    Table 96. Concert Pharmaceuticals Company Details
    Table 97. Concert Pharmaceuticals Business Overview
    Table 98. Concert Pharmaceuticals Morquio Syndrome Treatment Product
    Table 99. Concert Pharmaceuticals Revenue in Morquio Syndrome Treatment Business (2017-2022) & (US$ Million)
    Table 100. Concert Pharmaceuticals Recent Developments
    Table 101. Alexion Pharmaceuticals Company Details
    Table 102. Alexion Pharmaceuticals Business Overview
    Table 103. Alexion Pharmaceuticals Morquio Syndrome Treatment Product
    Table 104. Alexion Pharmaceuticals Revenue in Morquio Syndrome Treatment Business (2017-2022) & (US$ Million)
    Table 105. Alexion Pharmaceuticals Recent Developments
    Table 106. Roche Company Details
    Table 107. Roche Business Overview
    Table 108. Roche Morquio Syndrome Treatment Product
    Table 109. Roche Revenue in Morquio Syndrome Treatment Business (2017-2022) & (US$ Million)
    Table 110. Roche Recent Developments
    Table 111. Pfizer Company Details
    Table 112. Pfizer Business Overview
    Table 113. Pfizer Morquio Syndrome Treatment Product
    Table 114. Pfizer Revenue in Morquio Syndrome Treatment Business (2017-2022) & (US$ Million)
    Table 115. Pfizer Recent Developments
    Table 116. Lupin Company Details
    Table 117. Lupin Business Overview
    Table 118. Lupin Morquio Syndrome Treatment Product
    Table 119. Lupin Revenue in Morquio Syndrome Treatment Business (2017-2022) & (US$ Million)
    Table 120. Lupin Recent Developments
    Table 121. Cambrex Corporation Company Details
    Table 122. Cambrex Corporation Business Overview
    Table 123. Cambrex Corporation Morquio Syndrome Treatment Product
    Table 124. Cambrex Corporation Revenue in Morquio Syndrome Treatment Business (2017-2022) & (US$ Million)
    Table 125. Cambrex Corporation Recent Developments
    Table 126. Cipla Company Details
    Table 127. Cipla Business Overview
    Table 128. Cipla Morquio Syndrome Treatment Product
    Table 129. Cipla Revenue in Morquio Syndrome Treatment Business (2017-2022) & (US$ Million)
    Table 130. Cipla Recent Developments
    Table 131. Bayer Company Details
    Table 132. Bayer Business Overview
    Table 133. Bayer Morquio Syndrome Treatment Product
    Table 134. Bayer Revenue in Morquio Syndrome Treatment Business (2017-2022) & (US$ Million)
    Table 135. Bayer Recent Developments
    Table 136. Daiichi Sankyo Company Details
    Table 137. Daiichi Sankyo Business Overview
    Table 138. Daiichi Sankyo Morquio Syndrome Treatment Product
    Table 139. Daiichi Sankyo Revenue in Morquio Syndrome Treatment Business (2017-2022) & (US$ Million)
    Table 140. Daiichi Sankyo Recent Developments
    Table 141. Research Programs/Design for This Report
    Table 142. Key Data Information from Secondary Sources
    Table 143. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Morquio Syndrome Treatment Market Share by Type: 2021 VS 2028
    Figure 2. Morquio A Features
    Figure 3. Morquio B Features
    Figure 4. Global Morquio Syndrome Treatment Market Share by Application: 2021 VS 2028
    Figure 5. Hospital Case Studies
    Figure 6. Clinic Case Studies
    Figure 7. Others Case Studies
    Figure 8. Morquio Syndrome Treatment Report Years Considered
    Figure 9. Global Morquio Syndrome Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Morquio Syndrome Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Morquio Syndrome Treatment Market Share by Region: 2021 VS 2028
    Figure 12. Global Morquio Syndrome Treatment Market Share by Players in 2021
    Figure 13. Global Top Morquio Syndrome Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Morquio Syndrome Treatment as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Morquio Syndrome Treatment Revenue in 2021
    Figure 15. North America Morquio Syndrome Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 16. North America Morquio Syndrome Treatment Market Size Market Share by Type (2017-2028)
    Figure 17. North America Morquio Syndrome Treatment Market Size Market Share by Application (2017-2028)
    Figure 18. North America Morquio Syndrome Treatment Market Size Share by Country (2017-2028)
    Figure 19. United States Morquio Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Morquio Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Morquio Syndrome Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Morquio Syndrome Treatment Market Size Market Share by Type (2017-2028)
    Figure 23. Europe Morquio Syndrome Treatment Market Size Market Share by Application (2017-2028)
    Figure 24. Europe Morquio Syndrome Treatment Market Size Share by Country (2017-2028)
    Figure 25. Germany Morquio Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Morquio Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Morquio Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Morquio Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Morquio Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Morquio Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Morquio Syndrome Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 32. Asia Pacific Morquio Syndrome Treatment Market Size Market Share by Type (2017-2028)
    Figure 33. Asia Pacific Morquio Syndrome Treatment Market Size Market Share by Application (2017-2028)
    Figure 34. Asia Pacific Morquio Syndrome Treatment Market Size Share by Region (2017-2028)
    Figure 35. China Morquio Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan Morquio Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea Morquio Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia Morquio Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India Morquio Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia Morquio Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 41. Latin America Morquio Syndrome Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 42. Latin America Morquio Syndrome Treatment Market Size Market Share by Type (2017-2028)
    Figure 43. Latin America Morquio Syndrome Treatment Market Size Market Share by Application (2017-2028)
    Figure 44. Latin America Morquio Syndrome Treatment Market Size Share by Country (2017-2028)
    Figure 45. Mexico Morquio Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Brazil Morquio Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Middle East & Africa Morquio Syndrome Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Middle East and Africa Morquio Syndrome Treatment Market Size Market Share by Type (2017-2028)
    Figure 49. Middle East and Africa Morquio Syndrome Treatment Market Size Market Share by Application (2017-2028)
    Figure 50. Middle East and Africa Morquio Syndrome Treatment Market Size Share by Country (2017-2028)
    Figure 51. Turkey Morquio Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Morquio Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. UAE Morquio Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. BioMarin Revenue Growth Rate in Morquio Syndrome Treatment Business (2017-2022)
    Figure 55. Genzyme Corporation, Revenue Growth Rate in Morquio Syndrome Treatment Business (2017-2022)
    Figure 56. Shire Revenue Growth Rate in Morquio Syndrome Treatment Business (2017-2022)
    Figure 57. JCR Pharmaceuticals Revenue Growth Rate in Morquio Syndrome Treatment Business (2017-2022)
    Figure 58. Sanofi Revenue Growth Rate in Morquio Syndrome Treatment Business (2017-2022)
    Figure 59. Sangamo Therapeutics Revenue Growth Rate in Morquio Syndrome Treatment Business (2017-2022)
    Figure 60. Green Cross Revenue Growth Rate in Morquio Syndrome Treatment Business (2017-2022)
    Figure 61. Concert Pharmaceuticals Revenue Growth Rate in Morquio Syndrome Treatment Business (2017-2022)
    Figure 62. Alexion Pharmaceuticals Revenue Growth Rate in Morquio Syndrome Treatment Business (2017-2022)
    Figure 63. Roche Revenue Growth Rate in Morquio Syndrome Treatment Business (2017-2022)
    Figure 64. Pfizer Revenue Growth Rate in Morquio Syndrome Treatment Business (2017-2022)
    Figure 65. Lupin Revenue Growth Rate in Morquio Syndrome Treatment Business (2017-2022)
    Figure 66. Cambrex Corporation Revenue Growth Rate in Morquio Syndrome Treatment Business (2017-2022)
    Figure 67. Cipla Revenue Growth Rate in Morquio Syndrome Treatment Business (2017-2022)
    Figure 68. Bayer Revenue Growth Rate in Morquio Syndrome Treatment Business (2017-2022)
    Figure 69. Daiichi Sankyo Revenue Growth Rate in Morquio Syndrome Treatment Business (2017-2022)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Lukasiewicz Research Network

RELATED REPORTS

Global Sickle Cell Disease Treatment Market Size Status and Forecast 2021 2027
Global and United States Sickle Cell Disease Treatment Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-30X5811
Fri Apr 08 00:00:00 UTC 2022

Add to Cart

Global Fanconi Anemia Treatment Market Research Report 2022
Global Fanconi Anemia Treatment Market Research Report 2022

Fanconi anemia is indicated by shortness of breath frequent nasal bleeding weariness recurring viral infection and cold low stature and poor growth are all indications of fanconi anemia.The global Fanconi Anemia Treatment market size is projected to reach US million by 2028 from US million in 2021 at a CAGR of during 20222028.Fully considering the economic change by this health crisis Blood and Bone Marrow Transplant accounting for of the Fanconi Anemia Treatment global market in 2021 is projected to value US million by 2028 growing at a revised CAGR from 2022 to 2028.

120 Pages
Type: Report
Code: QYRE-Auto-32A10288
Wed Mar 30 00:00:00 UTC 2022

Add to Cart

Global Adrenoleukodystrophy Treatment Market Research Report 2022
Global Adrenoleukodystrophy Treatment Market Research Report 2022

Childhood cerebral ALD is known to progress rapidly in children between the ages of 3 and 10.The global Adrenoleukodystrophy Treatment market size is projected to reach US million by 2028 from US million in 2021 at a CAGR of during 20222028.Fully considering the economic change by this health crisis Oral Drugs accounting for of the Adrenoleukodystrophy Treatment global market in 2021 is projected to value US million by 2028 growing at a revised CAGR from 2022 to 2028.

120 Pages
Type: Report
Code: QYRE-Auto-14J10425
Wed Mar 23 00:00:00 UTC 2022

Add to Cart

Global Krabbe Disease Treatment Market Insights Forecast to 2028
Global Krabbe Disease Treatment Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-28R1610
Mon Mar 14 00:00:00 UTC 2022

Add to Cart